Nicholas Glover - Net Worth and Insider Trading

Nicholas Glover Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nicholas Glover owns 2 companies in total, including MEI Pharma Inc (MEIP) , and Sierra Oncology Inc (SRRA) .

Click here to see the complete history of Nicholas Glover’s form 4 insider trades.

Insider Ownership Summary of Nicholas Glover

Ticker	Comapny	Transaction Date	Type of Owner
MEIP	MEI Pharma Inc	2020-07-02	director
SRRA	Sierra Oncology Inc	2015-07-15	director & CEO and President

Nicholas Glover Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Nicholas Glover Ownership Network

Ownership Network List of Nicholas Glover

No Data

Ownership Network Relation of Nicholas Glover

Nicholas Glover Owned Company Details

What does MEI Pharma Inc do?

Who are the key executives at MEI Pharma Inc?

Nicholas Glover is the director of MEI Pharma Inc. Other key executives at MEI Pharma Inc include Chief Medical Officer Richard G Ghalie , 10 percent owner Amin Nathoo , and 10 percent owner Funicular Funds, Lp .

MEI Pharma Inc (MEIP) Insider Trades Summary

Over the past 18 months, Nicholas Glover made no insider transaction in MEI Pharma Inc (MEIP). Other recent insider transactions involving MEI Pharma Inc (MEIP) include a net purchase of 201,660 shares made by Anson Funds Management Lp , and a net purchase of 134,440 shares made by Funicular Funds, Lp .

In summary, during the past 3 months, insiders sold 0 shares of MEI Pharma Inc (MEIP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MEI Pharma Inc (MEIP) were sold and 336,100 shares were bought by its insiders, resulting in a net purchase of 336,100 shares.

MEI Pharma Inc (MEIP)'s detailed insider trading history can be found in Insider Trading Tracker table.

MEI Pharma Inc Insider Transactions

No Available Data

Nicholas Glover Mailing Address

Above is the net worth, insider trading, and ownership report for Nicholas Glover. You might contact Nicholas Glover via mailing address: C/o Pronai Therapeutics, Inc., 2150 - 885 West Georgia Street, Vancouver A1 V6c 3e8.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.